Cours suspendu

Autres langues Cerevel Therapeutics Holdings, Inc.

Actions

CERE

US15678U1280

Recherche biotechnologique et médicale

Temps Différé Nasdaq 22:00:00 31/07/2024			Varia. 5j.	Varia. 1 janv.
44,96 ^USD	+0,74%		-.--%	-

01/08/24	AbbVie finalise l'acquisition de Cerevel Therapeutics	MT
01/08/24	Cerevel Therapeutics Holdings, Inc. annonce des changements au sein de son conseil d'administration	CI

Autres langues

04/04/25	Entwistle & Cappucci LLP Files a Securities Class Action Against Cerevel Therapeutics Holdings, Inc., Bain Capital Investors, LLC and Pfizer, Inc.
31/03/25	Entwistle & Cappucci LLP is Investigating Potential Federal Securities Law Violations in Connection with Cerevel Therapeutics Holdings, Inc. (CERE)
05/08/24	Cerevel Therapeutics Holdings, Inc.(NasdaqCM:CERE) dropped from S&P Biotechnology Select Industry Index
05/08/24	Cerevel Therapeutics Holdings, Inc.(NasdaqCM:CERE) dropped from S&P Global BMI Index
05/08/24	Cerevel Therapeutics Holdings, Inc.(NasdaqCM:CERE) dropped from S&P TMI Index
02/08/24	RECOMENDACIONES DE LOS ANALISTAS UK/EE.UU.: Alphabet, Amazon, Lululemon, Intel, Qualcomm....
02/08/24	Analyst recommendations: Alphabet, Amazon, Lululemon, Intel, Qualcomm....
01/08/24	AbbVie Completes Acquisition of Cerevel Therapeutics
01/08/24	AbbVie Completes Acquisition of Cerevel Therapeutics
01/08/24	Cerevel Therapeutics Holdings, Inc. Announces Board Changes
01/08/24	AbbVie Completes Acquisition of Cerevel Therapeutics
01/08/24	Cerevel Therapeutics Holdings, Inc.(NasdaqCM:CERE) dropped from NASDAQ Composite Index
01/08/24	AbbVie Inc. completed the acquisition of Cerevel Therapeutics Holdings, Inc. from FMR LLC and others.
01/07/24	Cerevel Therapeutics Holdings, Inc.(NasdaqCM:CERE) added to Russell 1000 Dynamic Index
01/07/24	Cerevel Therapeutics Holdings, Inc.(NasdaqCM:CERE) added to Russell Midcap Growth Index
01/07/24	Cerevel Therapeutics Holdings, Inc.(NasdaqCM:CERE) added to Russell 1000 Index
01/07/24	Cerevel Therapeutics Holdings, Inc.(NasdaqCM:CERE) dropped from Russell 2000 Index
01/07/24	Cerevel Therapeutics Holdings, Inc.(NasdaqCM:CERE) dropped from Russell 2000 Growth Index
01/07/24	Cerevel Therapeutics Holdings, Inc.(NasdaqCM:CERE) added to Russell Midcap Index
01/07/24	Cerevel Therapeutics Holdings, Inc.(NasdaqCM:CERE) dropped from Russell 2000 Dynamic Index
01/07/24	Cerevel Therapeutics Holdings, Inc.(NasdaqCM:CERE) added to Russell 1000 Growth Index
14/05/24	Cerevel Therapeutics Holdings Insider Sold Shares Worth $2,105,125, According to a Recent SEC Filing
08/05/24	Cerevel Therapeutics Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
19/04/24	Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson's Disease
18/04/24	Cerevel Therapeutics' Potential Parkinson's Treatment Meets Primary Endpoint in Phase 3 Study